🇺🇸 FDA
Patent

US 12359223

Systems and methods for modulating chromosomal rearrangements

granted A61KA61K48/005

Quick answer

US patent 12359223 (Systems and methods for modulating chromosomal rearrangements) held by Editas Medicine, Inc. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Editas Medicine, Inc.
Grant date
Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K48/005